UNSPSC 51284401: Ceftaroline fosamil

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7P6FQA5D21. European Medicines Agency schedules Ceftaroline fosamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31648. Ceftaroline fosamil generally arises in the molecular formula C22H21N8O8PS4.

The term CEFTAROLINE FOSAMIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 1, 2008, list 59.) As of Q4 2014, CEFTAROLINE FOSAMIL remains the US FDA Preferred Term for this commodity. Ceftaroline fosamil bears US NLM identifiers UMLS ID C1873118 and NCI Concept Code C81034. SMILES: CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)O.CC(=O)[O-].O.

UNSPSC 51284401 Ceftaroline fosamil, a Commodity code, covers antibiotic pharmaceuticals for state and local health procurement. The source shows minimal recent activity directly under this code; the two posted opportunities involve unrelated pharmaceutical products—Doxycycline Hyclate and Ciprofloxacin Hydrochloride under an Illinois Department of Public Health piggyback contract, and Naloxone with drug deactivation systems under a Seminole County, Florida IFB. Neither opportunity solicits ceftaroline fosamil itself, and the code appears to see little current demand signal in posted state and local procurement notices.

The Illinois Department of Public Health awarded a $2,999,999.11 contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for antibiotic tablets under an IFB process with a 12-month initial term and two optional renewal years. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, with a July 26, 2023 response deadline (note the date discrepancy in the source), seeking 1,900 units of Naloxone and 800 drug deactivation systems annually through quarterly deliveries to the county's community health building. Neither opportunity targets ceftaroline fosamil specifically, suggesting the code may represent a niche or slow-moving pharmaceutical line in state and local procurement. Buyers operating under pharmaceutical cooperative vehicles like MMCAP Infuse and direct county health departments appear to be the primary issuing bodies when antibiotics are purchased, but recent activity under this specific commodity code does not support current pursuit.